These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 17159798)
21. Surgical soft tissue closure of severe diabetic foot infections: a combination of biologics, negative pressure wound therapy, and skin grafting. Ramanujam CL; Zgonis T Clin Podiatr Med Surg; 2012 Jan; 29(1):143-6. PubMed ID: 22243576 [TBL] [Abstract][Full Text] [Related]
22. Dermagraft in the treatment of diabetic foot ulcers. Bowering CK J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-29-32. PubMed ID: 10082605 [No Abstract] [Full Text] [Related]
23. [Healing of skin lesions in diabetic foot syndrome during hospitalization]. Jirkovská A Vnitr Lek; 2006 May; 52(5):459-64. PubMed ID: 16771090 [TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells combined with an artificial dermal substitute improve repair in full-thickness skin wounds. Leonardi D; Oberdoerfer D; Fernandes MC; Meurer RT; Pereira-Filho GA; Cruz P; Vargas M; Chem RC; Camassola M; Nardi NB Burns; 2012 Dec; 38(8):1143-50. PubMed ID: 22998897 [TBL] [Abstract][Full Text] [Related]
25. Biological basis of diabetic foot wounds. Clemens MW; Attinger CE Surg Technol Int; 2008; 17():89-95. PubMed ID: 18802887 [TBL] [Abstract][Full Text] [Related]
26. [Use of precultivative multipotent mesenchymal stromal cells isolated from autologic bone marrow in treatment of non-healing autoimmune gastric ulcers]. Askarov MB; Shumakov VI; Onishchenko NA; Krasheninnikov ME Khirurgiia (Mosk); 2009; (2):23-7. PubMed ID: 19365330 [TBL] [Abstract][Full Text] [Related]
27. [Repair of swine full-thickness cutaneous deficiency by autogenic BMSCs compounded with collagen membrane]. He L; Liu D; Bai C; Yan Y; Guan L; Pei X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Mar; 23(3):348-52. PubMed ID: 19366152 [TBL] [Abstract][Full Text] [Related]
28. Tissue-engineered skin containing mesenchymal stem cells improves burn wounds. Liu P; Deng Z; Han S; Liu T; Wen N; Lu W; Geng X; Huang S; Jin Y Artif Organs; 2008 Dec; 32(12):925-31. PubMed ID: 19133020 [TBL] [Abstract][Full Text] [Related]
29. Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Kirana S; Stratmann B; Lammers D; Negrean M; Stirban A; Minartz P; Koerperich H; Gastens MH; Götting C; Prohaska W; Kleesiek K; Tschoepe D Int J Clin Pract; 2007 Apr; 61(4):690-2. PubMed ID: 17394441 [TBL] [Abstract][Full Text] [Related]
30. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Blume PA; Walters J; Payne W; Ayala J; Lantis J Diabetes Care; 2008 Apr; 31(4):631-6. PubMed ID: 18162494 [TBL] [Abstract][Full Text] [Related]
31. [Mantova cell factory: a model for skin regeneration]. Negri S; Gasparato N; Fila C; Danese N; Farinato S; Bottoli C; Bellomi A G Ital Nefrol; 2009; 26 Suppl 45():S69-73. PubMed ID: 19382098 [TBL] [Abstract][Full Text] [Related]
32. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Caravaggi C; De Giglio R; Pritelli C; Sommaria M; Dalla Noce S; Faglia E; Mantero M; Clerici G; Fratino P; Dalla Paola L; Mariani G; Mingardi R; Morabito A Diabetes Care; 2003 Oct; 26(10):2853-9. PubMed ID: 14514591 [TBL] [Abstract][Full Text] [Related]
33. [The role of skin substitutes in the treatment of diabetic ulcer]. Martini J Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S32-3. PubMed ID: 9922890 [No Abstract] [Full Text] [Related]
34. Evaluation of wound healing effect on skin-defect nude mice by using human dermis-derived mesenchymal stem cells. Perng CK; Ku HH; Chiou SH; Chen IL; Tsai FT; Yang YP; Chang KY; Kao CL Transplant Proc; 2006 Nov; 38(9):3086-7. PubMed ID: 17112905 [TBL] [Abstract][Full Text] [Related]
35. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. Kakagia DD; Kazakos KJ; Xarchas KC; Karanikas M; Georgiadis GS; Tripsiannis G; Manolas C J Diabetes Complications; 2007; 21(6):387-91. PubMed ID: 17967712 [TBL] [Abstract][Full Text] [Related]
36. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Pietramaggiori G; Scherer SS; Mathews JC; Alperovich M; Yang HJ; Neuwalder J; Czeczuga JM; Chan RK; Wagner CT; Orgill DP Wound Repair Regen; 2008; 16(2):218-25. PubMed ID: 18318807 [TBL] [Abstract][Full Text] [Related]
37. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Dash NR; Dash SN; Routray P; Mohapatra S; Mohapatra PC Rejuvenation Res; 2009 Oct; 12(5):359-66. PubMed ID: 19929258 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Nakajima T; Iizuka H; Tsutsumi S; Kayakabe M; Takagishi K Spine (Phila Pa 1976); 2007 Oct; 32(22):2432-6. PubMed ID: 18090081 [TBL] [Abstract][Full Text] [Related]
39. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia]. Gu Y; Zhang J; Qi L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651 [TBL] [Abstract][Full Text] [Related]
40. Acceleration of sensory neural regeneration and wound healing with human mesenchymal stem cells in immunodeficient rats. Imaizumi T; Akita S; Akino K; Hirano A Stem Cells; 2007 Nov; 25(11):2956-63. PubMed ID: 17702984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]